Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics股價上漲，因該公司宣佈將在歐洲醫學腫瘤學會議（ESMO）上公佈其Phase 1/2癌症試驗數據。
Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics股價上漲，因該公司宣佈將在歐洲醫學腫瘤學會議（ESMO）上公佈其Phase 1/2癌症試驗數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間